Nexalin Technology (NXL) Shares Outstanding (Entity) (2021 - 2026)
Powered by 
Analysis
Nexalin Technology (NXL) Shares Outstanding (Entity) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.84 Bn | 174.23 Bn | 7.27 Bn | 1.73 Bn |
| 2 | Intuitive Surgical | 128.02 Bn | 122.81 Bn | 1.96 Bn | 353.90 Mn |
| 3 | Medtronic | 117.28 Bn | 108.46 Bn | 6.34 Bn | 1.28 Bn |
| 4 | Stryker | 103.92 Bn | 100.44 Bn | 4.50 Bn | 383.57 Mn |
| 5 | Boston Scientific | 63.51 Bn | 62.97 Bn | 3.85 Bn | 1.45 Bn |
| 6 | Edwards Lifesciences | 49.96 Bn | 45.70 Bn | 1.35 Bn | 576.60 Mn |
| 7 | Alcon | 32.86 Bn | 31.40 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.25 Bn | 30.30 Bn | 830.00 Mn | 377.40 Mn |
| 9 | Steris | 20.74 Bn | 20.26 Bn | 684.20 Mn | 97.50 Mn |
| 10 | Nexalin Technology | 3.42 Mn | 2.41 Mn | 8,897.00 | 733,457.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 733,457.00 |
| Mar 31, 2026 | 686,055.00 |
| Dec 31, 2025 | 639,545.00 |
| Sep 30, 2025 | 606,320.00 |
| Jun 30, 2025 | 580,598.00 |
| Mar 31, 2025 | 444,264.00 |
| Dec 31, 2024 | 307,192.00 |
| Sep 30, 2024 | 428,720.00 |
| Jun 30, 2024 | 252,885.00 |
| Mar 31, 2024 | 247,885.00 |
| Dec 31, 2023 | 247,885.00 |
| Sep 30, 2023 | 247,885.00 |
| Jun 30, 2023 | 242,885.00 |
| Mar 31, 2023 | 242,885.00 |
| Dec 31, 2022 | 185,747.00 |
| Sep 30, 2022 | 172,890.00 |
| Jun 30, 2022 | 163,505.00 |
| Mar 31, 2022 | 163,505.00 |
| Dec 31, 2021 | 162,664.00 |
| Sep 30, 2021 | 150,042.00 |